# US 2024/0189256 A1 · Compositions for pre-surgical nutritional supplements

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189256 A1
- Document ID: US20240189256A1
- Status: Published application
- Kind: A1
- Application number: 18/532,735
- Filed: 2023-12-07
- Published: 2024-06-13
- Earliest claimed: 2022-12-08
- Assignees: TM Nutrition LLC
- Applicants: TM Nutrition LLC
- Inventors: Thea MARX
- Web page: https://patentgrep.com/patent/US20240189256A1

## CPC

- A61K 31/07: Retinol compounds, e.g. vitamin A (retinoic acids A61K31/203)
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/125: containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21)
- A23L 33/15: Vitamins
- A23L 33/155: Vitamins A or D
- A23L 33/16: Inorganic salts, minerals or trace elements
- A23L 33/165: Complexes or chelates
- A23L 33/17: Amino acids, peptides or proteins
- A23L 33/175: Amino acids
- A23L 33/19: Dairy proteins
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A61K 9/009: {Sachets, pouches characterised by the material or function of the envelope (with gastric retention A61K9/0065; sachets which are not administered but function merely as a container are classified according to the content, e.g. sachets comprising powder for reconstitution of a drink A61K9/0095)}
- A61K 31/197: the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K31/205)
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/355: Tocopherols, e.g. vitamin E
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61K 31/4172: Imidazole-alkanecarboxylic acids, e.g. histidine
- A61K 31/455: Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A61K 31/59: Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K 31/593: 9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A61K 31/7016: Disaccharides, e.g. lactose, lactulose (lactobionic acid A61K31/7032)
- A61K 31/715: Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 33/18: Iodine; Compounds thereof
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 33/30: Zinc; Compounds thereof
- A61K 33/32: Manganese; Compounds thereof
- A61K 33/34: Copper; Compounds thereof
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Compositions and methods disclosed herein are configured to be administered to a subject prior to surgery. Compositions and methods disclosed herein are configured to provide nutrition and counteract physiological effects of a surgery. Compositions and methods disclosed herein can enable a subject to mitigate the stress response responsible for drastic shifts in metabolic and biochemical pathways, which can often leave a subject susceptible to a risk of higher mortality.

## Claims

### Claim 1

A composition comprising ingredients, wherein the ingredients comprise, by percent of total mass of the ingredients: i) about 0.00005% w/w to about 0.001% w/w Vitamin A; ii) about 5% w/w to about 15% w/w Vitamin C; iii) about 0.0001% w/w to about 0.01% w/w Vitamin D; iv) about 0.1% w/w to about 10% w/w Vitamin E; v) about 5% to about 15% w/w pantothenic acid; vi) about 0.1% w/w to about 10% w/w calcium; vii) about 0.1% w/w to about 10% w/w magnesium; viii) about 0.01% to about 1% w/w zinc; ix) about 0.001% w/w to about 0.01% w/w selenomethionine; x) about 0.001% w/w to about 0.01% w/w copper; xi) about 0.1% w/w to about 10% w/w potassium; and xii) about 25% w/w to about 75% w/w trehalose.

### Claim 2 (depends on 1)

The composition of claim 1, the ingredients further comprising: xiii) about 5% w/w to about 25% w/w arabinogalactan.

### Claim 3 (depends on 1)

The composition of claim 1, the ingredients further comprising: xiii) about 5% w/w to about 25% w/w arabinogalactan; xiv) about 5% w/w to about 25% w/w L-citrulline; xv) about 0.1% w/w to about 10% w/w chromium; xvi) about 0.001% w/w to about 0.1% w/w manganese; xvii) about 5% w/w to about 15% w/w carnosine; and xviii) about 0.1% w/w to about 10% w/w gelatin.

### Claim 4 (depends on 1)

The composition of claim 1, the ingredients comprising: i) about 0.0001% w/w Vitamin A; ii) about 9% w/w Vitamin C; iii) about 0.002% w/w Vitamin D; iv) about 1.5% w/w Vitamin E; v) about 7% w/w pantothenic acid; vi) about 1% w/w calcium; vii) about 1% w/w magnesium; viii) about 0.1% w/w zinc; ix) about 0.002% w/w selenomethionine; x) about 0.003% w/w copper; xi) about 0.9% w/w potassium; and xii) about 51% w/w trehalose.

### Claim 5 (depends on 3)

The composition of claim 3, the ingredients comprising xiii) about 13% w/w arabinogalactan.

### Claim 6 (depends on 3)

The composition of claim 3, the ingredients comprising: xiii) about 13% w/w arabinogalactan; xiv) about 11% w/w L-citrulline; xv) about 1% w/w chromium; xvi) about 0.04% w/w manganese; xvii) about 7% w/w carnosine; and xviii) about 1% w/w gelatin.

### Claim 7 (depends on 1)

The composition of claim 1, further comprising a solvent, wherein the ingredients are mixed into the solvent to provide a potable mixture that is suitable for human consumption.

### Claim 8 (depends on 7)

The composition of claim 7, wherein the solvent is water.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the composition is hypoallergenic.

### Claim at position 10

10-32. (canceled)

### Claim 33

An article comprising: a) a composition; and b) packaging acceptable for a nutritional product, wherein the composition is disposed inside the packaging, wherein the composition comprises ingredients, wherein the ingredients comprise, by percent of total mass of the ingredients: i) about 0.00005% w/w to about 0.001% w/w Vitamin A; ii) about 5% w/w to about 15% w/w Vitamin C; iii) about 0.0001% w/w to about 0.01% w/w Vitamin D; iv) about 0.1% w/w to about 10% w/w Vitamin E; v) about 5% to about 15% w/w pantothenic acid; vi) about 0.1% w/w to about 10% w/w calcium; vii) about 0.1% w/w to about 10% w/w magnesium; viii) about 0.01% to about 1% w/w zinc; ix) about 0.001% w/w to about 0.01% w/w selenomethionine; x) about 0.001% w/w to about 0.01% w/w copper; xi) about 0.1% w/w to about 10% w/w potassium; and xii) about 25% w/w to about 75% w/w trehalose.

### Claim at position 12

-36. (canceled)

### Claim 37 (depends on 33)

The article of claim 33, the ingredients further comprising about 5% w/w to about 25% w/w arabinogalactan.

### Claim 38 (depends on 33)

The article of claim 33, the ingredients further comprising: xiii) about 5% w/w to about 25% w/w arabinogalactan; xiv) about 5% w/w to about 25% w/w L-citrulline; xv) about 0.1% w/w to about 10% w/w chromium; xvi) about 0.001% w/w to about 0.1% w/w manganese; xvii) about 5% w/w to about 15% w/w carnosine; and xviii) about 0.1% w/w to about 10% w/w gelatin.

### Claim 39 (depends on 33)

The article of claim 33, the ingredients comprising: i) about 0.0001% w/w Vitamin A; ii) about 9% w/w Vitamin C; iii) about 0.002% w/w Vitamin D; iv) about 1.5% w/w Vitamin E; v) about 7% w/w pantothenic acid; vi) about 1% w/w calcium; vii) about 1% w/w magnesium; viii) about 0.1% w/w zinc; ix) about 0.002% w/w selenomethionine; x) about 0.003% w/w copper; xi) about 0.9% w/w potassium; and xii) about 51% w/w trehalose.

### Claim 40 (depends on 38)

The article of claim 38, the ingredients comprising xiii) about 13% w/w arabinogalactan.

### Claim 41 (depends on 38)

The article of claim 38, the ingredients comprising: xiii) about 13% w/w arabinogalactan; xiv) about 11% w/w L-citrulline; xv) about 1% w/w chromium; xvi) about 0.04% w/w manganese; xvii) about 7% w/w carnosine; and xviii) about 1% w/w gelatin.

### Claim 42 (depends on 33)

The article of claim 33, further comprising a solvent, wherein the ingredients are mixed into the solvent to provide a potable mixture that is suitable for human consumption.

### Claim 43 (depends on 42)

The article of claim 42, wherein the solvent is water.

### Claim 44 (depends on 33)

The article of claim 33, wherein the composition is hypoallergenic.

### Claim 45 (depends on 33)

The article of claim 33, wherein the article is formulated as a sachet.

### Claim 46 (depends on 33)

The article of claim 33, wherein the article is formulated for reconstitution prior to consumption.
